{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:14:04Z","timestamp":1791314044325,"version":"4.3.1"},"update-to":[{"DOI":"10.1016\/j.heliyon.2023.e18090","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"reference-count":270,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006761","name":"University of Vigo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.heliyon.2023.e18090","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T02:21:19Z","timestamp":1688782879000},"page":"e18090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["RETRACTED: Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms"],"prefix":"10.1016","volume":"9","author":[{"given":"Md Mominur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Rezaul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shopnil","family":"Akash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Emon","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afroza Alam","family":"Tumpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-1956","authenticated-orcid":false,"given":"Galib Muhammad","family":"Abrar Ishtiaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limon","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anees Ahmed","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Al Abdulmonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-9737","authenticated-orcid":false,"given":"Jesus","family":"Simal-Gandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e18090_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.881225","article-title":"Parathyroid carcinoma all-in-one, a rare life-threatening case with multiple systemic manifestations: case report and review of the literature","volume":"13","author":"Zelano","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41582-022-00686-x","article-title":"From the prodromal stage of multiple sclerosis to disease prevention","volume":"18","author":"Marrie","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib3","first-page":"637","article-title":"Critical review: vegetables and fruit in the prevention of chronic diseases","volume":"51","author":"Boeing","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib4","volume":"vol. 2022","author":"Rahman","year":"2022"},{"key":"10.1016\/j.heliyon.2023.e18090_bib5","first-page":"360","article-title":"In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice","volume":"16","author":"Seeram","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib6","article-title":"Therapeutic applications of pomegranate (Punica granatum","volume":"13","author":"Jurenka","year":"2008","journal-title":"L.): a review"},{"key":"10.1016\/j.heliyon.2023.e18090_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1541-4337.2010.00131.x","article-title":"Pomegranate and its many functional components as related to human health: a review","volume":"9","author":"Viuda\u2010Martos","year":"2010","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.heliyon.2023.e18090_bib8","series-title":"Dietary Antioxidants and Paraoxonases against LDL Oxidation and Atherosclerosis Development","first-page":"263","author":"Aviram","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib9","first-page":"9","article-title":"Antioxidative potential of pomegranate peel extract: in vitro and in vivo studies","volume":"54","author":"Mandi\u0107-Kova\u010devi\u0107","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e18090_bib10","first-page":"9160","article-title":"Pomegranate fruit and juice (cv. Mollar), rich in ellagitannins and anthocyanins, also provide a significant content of a wide range of proanthocyanidins","volume":"67","author":"D\u00edaz-Mula","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib11","first-page":"98","volume":"29","author":"Naqvi","year":"1976","journal-title":"Antibacterial, antifungal and anthelmintic studies on Ochrocarpus longifolius"},{"key":"10.1016\/j.heliyon.2023.e18090_bib12","first-page":"369","article-title":"Role of selected Indian plants in management of type 2 diabetes: a review","volume":"10","author":"Saxena","year":"2004","journal-title":"stl"},{"key":"10.1016\/j.heliyon.2023.e18090_bib13","first-page":"2709","article-title":"Antioxidant, anti-inflammatory, antimicrobial, and anticancer activities of pomegranate juice concentrate","volume":"15","author":"Habib","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e18090_bib14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/10408391003748100","article-title":"The bioactivity of pomegranate: impact on health and disease","volume":"51","author":"Faria","year":"2011","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2023.e18090_bib15","first-page":"177","article-title":"Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer","volume":"109","author":"Lansky","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib16","series-title":"Seminars in Cancer Biology","first-page":"377","article-title":"Pomegranate derived products for cancer chemoprevention","author":"Syed","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib17","first-page":"38","article-title":"Pomegranate fruit extract modulates UV\u2010B\u2013mediated phosphorylation of mitogen\u2010activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes","volume":"81","author":"Afaq","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1751-1097.2007.00157.x","article-title":"Inhibition of UVB\u2010mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx","volume":"83","author":"Zaid","year":"2007","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib19","first-page":"245","article-title":"Propionate as a health-promoting microbial metabolite in the human gut","volume":"69","author":"Hosseini","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib20","series-title":"SKH-1 Hairless Mice","article-title":"Inhibitory effect of oral feeding of pomegranate fruit extract on UVB-induced skin carcinogenesis","author":"Afaq","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib21","first-page":"1000","article-title":"The inhibitory effect of anti-tumor polysaccharide from Punica granatum on metastasis","volume":"103","author":"Varghese","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib22","doi-asserted-by":"crossref","unstructured":"A. L. Z. Y. S. J. P. e. d. c. e. a. NP and a. a. i. b. c. c. i. v. C. P. Research, Heber D Chen S, vol. 3, pp. 108\u2013113, 2010.","DOI":"10.1158\/1940-6207.CAPR-08-0225"},{"key":"10.1016\/j.heliyon.2023.e18090_bib23","first-page":"1","article-title":"Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy","volume":"16","author":"Wu","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib24","first-page":"103","article-title":"Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development","volume":"57","author":"Tian","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14715\/cmb\/2018.64.7.15","article-title":"Pomegranate peel extract inhibits expression of \u00ce2-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells","volume":"64","author":"Bagheri","year":"2018","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib26","first-page":"647","article-title":"Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer","volume":"136","author":"Rocha","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib27","first-page":"421","article-title":"Punicic acid is an \u03c9-5 fatty acid capable of inhibiting breast cancer proliferation","volume":"36","author":"Grossmann","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib28","first-page":"1638","article-title":"The antioxidant potency of Punica granatum L. Fruit peel reduces cell proliferation and induces apoptosis on breast cancer","volume":"14","author":"Dikmen","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib29","first-page":"8644","article-title":"Potential anti-inflammatory effects of the hydrophilic fraction of pomegranate (Punica granatum L.) seed oil on breast cancer cell lines","volume":"19","author":"Costantini","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib30","first-page":"102","article-title":"Gene expression changes in pomegranate peel extract-treated triple-negative breast cancer cells","volume":"7","author":"Ahmadiankia","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib31","first-page":"371","article-title":"Prostate cancer prevention through pomegranate fruit","volume":"5","author":"Malik","year":"2006"},{"key":"10.1016\/j.heliyon.2023.e18090_bib32","first-page":"2662","article-title":"Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-\u03baB-dependent mechanism","volume":"7","author":"Rettig","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib33","first-page":"497","article-title":"Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy","volume":"74","author":"Wang","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib34","first-page":"3251","article-title":"Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell","volume":"12","author":"Lee","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib35","first-page":"41","article-title":"A phase II randomized placebo\u2010controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance","volume":"81","author":"Jarrard","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib36","first-page":"644","article-title":"Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model","volume":"33","author":"Adhami","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib37","first-page":"55","article-title":"Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF\u2013IGFBP axis","volume":"20","author":"Koyama","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib38","article-title":"Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis","volume":"5","author":"Wang","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib39","first-page":"233","article-title":"Apoptosis by dietary factors: the suicide solution for delaying cancer growth","volume":"28","author":"Khan","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib40","first-page":"227","article-title":"Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro","volume":"80","author":"Li","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib41","series-title":"Punicalagin and Ellagic Acid Demonstrate Antimutagenic Activity and Inhibition of Benzo [a] Pyrene Induced DNA Adducts","volume":"2014","author":"Zahin","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib42","first-page":"2814","article-title":"Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: possible role of miR-126\/VCAM-1 and miR-126\/PI3K\/AKT\/mTOR","volume":"34","author":"Banerjee","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib43","first-page":"3475","article-title":"Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice","volume":"67","author":"Khan","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib44","first-page":"1224","article-title":"An aqueous pomegranate peel extract inhibits neutrophil myeloperoxidase in vitro and attenuates lung inflammation in mice","volume":"49","author":"Bachoual","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib45","first-page":"2563","article-title":"A new G-quadruplex with hairpin loop immediately upstream of the human BCL2 P1 promoter modulates transcription","volume":"138","author":"Onel","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib46","first-page":"725","article-title":"Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats","volume":"45","author":"Boateng","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib47","first-page":"980","article-title":"Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells","volume":"54","author":"Adams","year":"2006"},{"key":"10.1016\/j.heliyon.2023.e18090_bib48","first-page":"1973","article-title":"MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: critical issues to discern between modulatory effects and potential artefacts","volume":"59","author":"Nu\u00f1ez\u2010S\u00e1nchez","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib49","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1021\/jf072741q","article-title":"Pomegranate oil analysis with emphasis on MALDI-TOF\/MS triacylglycerol fingerprinting","volume":"55","author":"Kaufman","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib50","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/jf063443g","article-title":"Evaluation of antioxidant activity and preventing DNA damage effect of pomegranate extracts by chemiluminescence method","volume":"55","author":"Guo","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib51","first-page":"C626","article-title":"Optimization of extraction conditions of total phenolics, antioxidant activities, and anthocyanin of oregano, thyme, terebinth, and pomegranate","volume":"75","author":"Rababah","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib52","first-page":"C765","article-title":"Storage stability of sterilized liquid extracts from pomegranate peel","volume":"77","author":"Qu","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib53","first-page":"63","article-title":"Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice","volume":"348","author":"Seeram","year":"2004"},{"key":"10.1016\/j.heliyon.2023.e18090_bib54","first-page":"2481","article-title":"Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours","volume":"136","author":"Seeram","year":"2006"},{"key":"10.1016\/j.heliyon.2023.e18090_bib55","first-page":"145","article-title":"Phenolic compounds impact on rheumatoid arthritis, inflammatory bowel disease and microbiota modulation","volume":"13","author":"Direito","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib56","first-page":"10181","article-title":"Urolithins, intestinal microbial metabolites of pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay","volume":"57","author":"Bialonska","year":"2009"},{"key":"10.1016\/j.heliyon.2023.e18090_bib57","first-page":"390","article-title":"Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects","volume":"11","author":"Seeram","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib58","first-page":"784","article-title":"Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF--induced inflammation and associated molecular markers in human aortic endothelial cells","volume":"56","author":"Esp\u0131n","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib59","first-page":"18","article-title":"Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice","volume":"42","author":"Cerd\u00e1","year":"2003"},{"key":"10.1016\/j.heliyon.2023.e18090_bib60","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1021\/jf020842c","article-title":"Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic","volume":"51","author":"Cerd\u00e1","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib61","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/jf061674h","article-title":"Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers","volume":"54","author":"Mertens-Talcott","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib62","first-page":"10476","article-title":"Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans","volume":"55","author":"Esp\u00edn","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib63","first-page":"7732","article-title":"Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland","volume":"55","author":"Seeram","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib64","first-page":"311","article-title":"Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice","volume":"54","author":"Gonz\u00e1lez\u2010Sarr\u00edas","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib65","volume":"vol. 2013","author":"Viladomiu","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib66","first-page":"2712","volume":"27","author":"Amin","year":"2009","journal-title":"Perspectives for cancer prevention with natural compounds"},{"key":"10.1016\/j.heliyon.2023.e18090_bib67","article-title":"Therapeutic properties of Punica granatum L (pomegranate) and its applications in lung\u2010based diseases: a detailed review","volume":"45","author":"Shaikh","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib68","first-page":"57","volume":"100","author":"Hanahan","year":"2000","journal-title":"The Hallmarks of Cancer"},{"key":"10.1016\/j.heliyon.2023.e18090_bib69","first-page":"646","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib70","volume":"11","author":"Senga","year":"2021","journal-title":"Hallmarks of Cancer\u2014the New Testament"},{"key":"10.1016\/j.heliyon.2023.e18090_bib71","first-page":"1787","article-title":"STAT3 interactors as potential therapeutic targets for cancer treatment","volume":"19","author":"Laudisi","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib72","series-title":"Seminars in Cancer Biology","article-title":"Epigenetics of glioblastoma multiforme: from molecular mechanisms to therapeutic approaches","author":"Uddin","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e18090_bib73","first-page":"1591","article-title":"Structural biology of STAT3 and its implications for anticancer therapies development","volume":"19","author":"Sgrignani","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib74","first-page":"2708","article-title":"Protein tyrosine phosphatases as potential regulators of STAT3 signaling","volume":"19","author":"Kim","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib75","first-page":"40","article-title":"The complex roles of STAT3 and STAT5 in maintaining redox balance: lessons from STAT-mediated xCT expression in cancer cells","volume":"451","author":"Linher-Melville","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib76","first-page":"eaax7945","volume":"vol. 6","author":"Busker","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e18090_bib77","first-page":"1681","article-title":"Targeting STAT3 in cancer with nucleotide therapeutics","volume":"11","author":"K Lau","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2023.e18090_bib79","first-page":"262","article-title":"Multitargeted therapy of cancer by ellagitannins","volume":"269","author":"Heber","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib80","first-page":"76","article-title":"Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives","volume":"38","author":"Weng","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib81","first-page":"42","article-title":"STAT3 in cancer: a double edged sword","volume":"98","author":"Avalle","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib82","first-page":"144","article-title":"Mechanistic pathways and molecular targets of plant-derived anticancer ent-kaurane diterpenes","volume":"10","author":"Sarwar","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e18090_bib83","article-title":"Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer","volume":"268","author":"Aziz","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib84","first-page":"187","article-title":"Cross-talk between rho GTPases and PI3K in the neutrophil","volume":"10","author":"McCormick","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib85","first-page":"3050","article-title":"Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination","volume":"143","author":"Yu","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib86","first-page":"929","article-title":"Insulin receptor and GPCR crosstalk stimulates YAP via PI3K and PKD in pancreatic cancer cells","volume":"15","author":"Hao","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib87","first-page":"372","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib88","first-page":"1","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib89","first-page":"140","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib90","article-title":"Targeting PI3K\/Akt\/mTOR signaling pathway by polyphenols: implication for cancer therapy","volume":"255","author":"Mirza-Aghazadeh-Attari","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e18090_bib91","article-title":"Fabrication techniques for production of thermoplastic-based microfluidics Devices","volume":"4","author":"Wang","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib92","volume":"vol. 2018","author":"Li","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12263-007-0056-z","article-title":"The interactions of flavonoids within neuronal signalling pathways","volume":"2","author":"Spencer","year":"2007","journal-title":"Genes & Nutrition"},{"key":"10.1016\/j.heliyon.2023.e18090_bib94","doi-asserted-by":"crossref","first-page":"ES60","DOI":"10.1017\/S0007114508965776","article-title":"Flavonoids: modulators of brain function?","volume":"99","author":"Spencer","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e18090_bib95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2023.e18090_bib96","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2010.03.029","article-title":"Role of the Akt\/mTOR survival pathway in cisplatin resistance in ovarian cancer cells","volume":"394","author":"Peng","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2023.e18090_bib97","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2023.e18090_bib98","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1751-1097.2011.01063.x","article-title":"Pomegranate fruit extract inhibits UVB\u2010induced inflammation and proliferation by modulating NF\u2010\u03baB and MAPK signaling pathways in mouse skin","volume":"88","author":"Khan","year":"2012","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/taap.2001.9276","article-title":"Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (\u2212)-epigallocatechin-3-gallate","volume":"176","author":"Katiyar","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib100","first-page":"493","article-title":"Tumor necrosis factor-\u03b1-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and I\u03baB kinase 1\/2 in human alveolar epithelial cells","volume":"59","author":"Chen","year":"2001"},{"key":"10.1016\/j.heliyon.2023.e18090_bib101","first-page":"67","article-title":"Primary prevention of skin cancer in children and adolescents: a review of the literature","volume":"25","author":"Hart","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib102","first-page":"778","article-title":"Regulation of tissue homeostasis by NF-\u03baB signalling: implications for inflammatory diseases","volume":"9","author":"Pasparakis","year":"2009"},{"key":"10.1016\/j.heliyon.2023.e18090_bib103","first-page":"715","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib104","first-page":"11","article-title":"Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids","volume":"66","author":"Schubert","year":"1999"},{"key":"10.1016\/j.heliyon.2023.e18090_bib105","first-page":"380","article-title":"Punica granatum is more effective to prevent gastric disorders induced by Helicobacter pylori or any other stimulator in humans","volume":"10","author":"Rahimi","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib106","first-page":"1096","article-title":"A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines","volume":"44","author":"Mix","year":"2001"},{"key":"10.1016\/j.heliyon.2023.e18090_bib107","first-page":"717","article-title":"Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism","volume":"21","author":"Larrosa","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib108","first-page":"2195","article-title":"Signaling to NF-\u03baB","volume":"18","author":"Hayden","year":"2004"},{"key":"10.1016\/j.heliyon.2023.e18090_bib109","first-page":"385","article-title":"A comprehensive review of Punica granatum (pomegranate) properties in toxicological, pharmacological, cellular and molecular biology researches","volume":"11","author":"Rahimi","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib110","first-page":"301","article-title":"NF-\u03baB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002"},{"key":"10.1016\/j.heliyon.2023.e18090_bib111","first-page":"163","article-title":"Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice","volume":"28","author":"Khan","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib112","first-page":"14813","article-title":"Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer","volume":"102","author":"Malik","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib113","first-page":"136","volume":"11","author":"Rahmani","year":"2017","journal-title":"Potential antitumor effects of pomegranates and its ingredients"},{"key":"10.1016\/j.heliyon.2023.e18090_bib114","first-page":"2733","article-title":"Punicalagin in cancer prevention\u2014via signaling pathways targeting","volume":"13","author":"Berdowska","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib115","first-page":"600","article-title":"Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K\/AKT\/mTOR signaling pathway in mES\/EB-derived endothelial-like cells","volume":"43","author":"Kim","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib116","first-page":"1","article-title":"Cancer metastasis: issues and challenges","volume":"36","author":"Qian","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib117","first-page":"357","article-title":"Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition","volume":"33","author":"Zaino","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib118","first-page":"317","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib119","first-page":"44","article-title":"Prediction of histological grade of endometrial cancer by means of MRI","volume":"103","author":"Bonatti","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib120","first-page":"8983","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003"},{"key":"10.1016\/j.heliyon.2023.e18090_bib121","first-page":"1978","article-title":"Akt, FoxO and regulation of apoptosis","volume":"1813","author":"Zhang","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib122","first-page":"346","article-title":"Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression","volume":"765","author":"Zhang","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib123","article-title":"Isolation and chemopreventive evaluation of novel naphthoquinone compounds from Alkanna tinctoria","volume":"24","author":"Tung","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib124","first-page":"345","article-title":"Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk","volume":"49","author":"Aqil","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib125","first-page":"487","article-title":"Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer","volume":"18","author":"Ahmed","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopha.2008.07.093","article-title":"Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells","volume":"63","author":"Fjaeraa","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.heliyon.2023.e18090_bib127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/01635581.2016.1115094","article-title":"Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis","volume":"68","author":"Bishayee","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.heliyon.2023.e18090_bib128","first-page":"469","article-title":"Anticancer activities of pomegranate extracts and genistein in human breast cancer cells","volume":"8","author":"Jeune","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib129","article-title":"Pomegranate bioactive constituents suppress cell proliferation and induce apoptosis in an experimental model of hepatocellular carcinoma: role of Wnt\/\u03b2-catenin signaling pathway","volume":"2013","author":"Bhatia","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/2229-516X.157154","article-title":"Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells","volume":"5","author":"Gsmaa","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.heliyon.2023.e18090_bib131","first-page":"1803","article-title":"Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells","volume":"37","author":"Kiraz","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib132","first-page":"1","article-title":"A comprehensive review on phytochemistry, bioactivity and medicinal value of bioactive compounds of pomegranate (Punica granatum)","author":"Ranjha","year":"2021","journal-title":"Adv. Tradit. Med."},{"key":"10.1016\/j.heliyon.2023.e18090_bib133","doi-asserted-by":"crossref","first-page":"315","DOI":"10.9734\/EJMP\/2014\/6417","article-title":"Phenolic constituents of pomegranate peels (Punica granatum L.) cultivated in Oman","volume":"4","author":"Al-Rawahi","year":"2014","journal-title":"Eur. J. Med. Plants"},{"key":"10.1016\/j.heliyon.2023.e18090_bib134","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/1871520621666210726143553","article-title":"An insight into anticancer bioactives from Punica granatum (Pomegranate)","volume":"22","author":"Sharma","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1541-4337.2010.00131.x","article-title":"Pomegranate and its many functional components as related to human health: a review","volume":"9","author":"Viuda\u2010Martos","year":"2010","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.heliyon.2023.e18090_bib136","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib137","first-page":"367","volume":"13","author":"Taghavi","year":"2012","journal-title":"Increased trend of breast cancer mortality in Iran"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18090_bib138","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12032-022-01804-x","article-title":"Risk factors for breast cancer in women: an update review","volume":"39","author":"Fakhri","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib139","first-page":"4956","article-title":"N-Substituted calothrixin B derivatives inhibited the proliferation of HL-60 promyelocytic leukemia cells","volume":"23","author":"Hatae","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib140","first-page":"1119","article-title":"Influence of delay on survival in patients with breast cancer: a systematic review","volume":"353","author":"Richards","year":"1999"},{"key":"10.1016\/j.heliyon.2023.e18090_bib141","series-title":"Seminars in Oncology","first-page":"1","article-title":"Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer","author":"Norton","year":"1999"},{"key":"10.1016\/j.heliyon.2023.e18090_bib142","first-page":"153","article-title":"Current controversies in breast cancer management","volume":"36","author":"Morrow","year":"1999"},{"key":"10.1016\/j.heliyon.2023.e18090_bib143","first-page":"93","article-title":"Gene therapy strategies for carcinoma of the breast","volume":"44","author":"Ruppert","year":"1997"},{"key":"10.1016\/j.heliyon.2023.e18090_bib144","first-page":"108","article-title":"Pomegranate ellagitannin\u2013derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro","volume":"3","author":"Adams","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib145","first-page":"345","article-title":"Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture","volume":"13","author":"Mehta","year":"2004"},{"key":"10.1016\/j.heliyon.2023.e18090_bib146","first-page":"1087","article-title":"Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro","volume":"24","author":"Dai","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib147","series-title":"Male reproductive system","first-page":"431","author":"Knoblaugh","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib148","first-page":"379","article-title":"The role of the prostate in male fertility, health and disease","volume":"13","author":"Verze","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib149","doi-asserted-by":"crossref","unstructured":"G. Attard, C. Parker, and R. J. P. Eeles, Schroff der F, Tomlins SA, Tannock I, Drake CG, de Bono JS. 2016, vol. 387, pp. 70\u201382.","DOI":"10.1016\/S0140-6736(14)61947-4"},{"key":"10.1016\/j.heliyon.2023.e18090_bib150","first-page":"35","article-title":"The zonal anatomy of the prostate","volume":"2","author":"McNeal","year":"1981"},{"key":"10.1016\/j.heliyon.2023.e18090_bib151","first-page":"565","article-title":"Prostate development: a historical perspective","volume":"76","author":"Timms","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib152","first-page":"1050","article-title":"Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men","volume":"105","author":"Zlotta","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib153","first-page":"790","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"Bray","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib154","first-page":"1313","article-title":"Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta\u2010analysis","volume":"114","author":"Johnson","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib155","first-page":"e191","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e18090_bib156","series-title":"Cancer Statistics","first-page":"7","volume":"vol. 71","author":"Siegel","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib157","first-page":"68","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib158","first-page":"19","article-title":"Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo","volume":"143","author":"Ming","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib159","article-title":"Microrna 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin \u03b21","volume":"9","author":"Zhao","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mnfr.200800150","article-title":"Gene expression, cell cycle arrest and MAPK signalling regulation in Caco\u20102 cells exposed to ellagic acid and its metabolites, urolithins","volume":"53","author":"Gonz\u00e1lez\u2010Sarr\u00edas","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.heliyon.2023.e18090_bib161","first-page":"2180","article-title":"Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins","volume":"58","author":"Kasimsetty","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib162","first-page":"627","article-title":"Punica granatum suppresses colon cancer through downregulation of Wnt\/\u03b2-Catenin in rat model","volume":"27","author":"Ahmed","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib163","first-page":"665","article-title":"Targeting the canonical Wnt\/\u03b2\u2010catenin pathway in hematological malignancies","volume":"106","author":"Ashihara","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib164","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10585-016-9807-9","article-title":"The current status of checkpoint inhibitors in metastatic bladder cancer","volume":"33","author":"Fahmy","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.heliyon.2023.e18090_bib165","first-page":"187","article-title":"Novel non invasive diagnostic strategies in bladder cancer","volume":"89","author":"Truta","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib166","first-page":"59","article-title":"Evaluation of different extraction methods from pomegranate whole fruit or peels and the antioxidant and antiproliferative activity of the polyphenolic fraction","volume":"202","author":"Masci","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib167","first-page":"1","article-title":"Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis","volume":"13","author":"Lee","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib168","first-page":"415","article-title":"Anti\u2010proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53\/miR\u201034a Axis","volume":"29","author":"Zhou","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib169","first-page":"102","article-title":"Recent advances and developments in treatment strategies against pancreatic cancer","volume":"4","author":"Fryer","year":"2009"},{"key":"10.1016\/j.heliyon.2023.e18090_bib170","first-page":"2699","article-title":"Pomegranate extract induces cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells","volume":"31","author":"Nair","year":"2011","journal-title":"stl"},{"key":"10.1016\/j.heliyon.2023.e18090_bib171","first-page":"28","article-title":"Anti-cancer activity of pomegranate and its biophenols; general review","volume":"6","author":"Hajleh","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib172","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/01635581.2016.1192205","article-title":"Effect of pomegranate hull extract on liver neoplastic changes in rats: more than an antioxidant","volume":"68","author":"El-Ashmawy","year":"2016","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.heliyon.2023.e18090_bib173","first-page":"888","article-title":"Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms","volume":"32","author":"Bishayee","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib174","first-page":"178","article-title":"Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis","volume":"24","author":"Bishayee","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib175","first-page":"1174","article-title":"Galactomannan endowed biogenic silver nanoparticles exposed enhanced cancer cytotoxicity with excellent biocompatibility","volume":"118","author":"Padinjarathil","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib176","first-page":"1","article-title":"A systematic determination of polyphenols constituents and cytotoxic ability in fruit parts of pomegranates derived from five Chinese cultivars","volume":"5","author":"Li","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib177","first-page":"158","article-title":"Pomegranate peel extract polyphenols induced apoptosis in human hepatoma cells by mitochondrial pathway","volume":"93","author":"Song","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib178","first-page":"211","article-title":"Exploiting antidiabetic activity of silver nanoparticles synthesized using Punica granatum leaves and anticancer potential against human liver cancer cells (HepG2)","volume":"46","author":"Saratale","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.heliyon.2023.e18090_bib179","first-page":"1313","article-title":"Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study","volume":"13","author":"Badawi","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib180","first-page":"286","article-title":"Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450\u20103A activity: comparison with grapefruit juice","volume":"47","author":"Farkas","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e18090_bib181","first-page":"7397","article-title":"Insect antimicrobial peptides: potential tools for the prevention of skin cancer","volume":"100","author":"Tonk","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib182","first-page":"1466","article-title":"A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity","volume":"98","author":"Joseph","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib183","first-page":"157","article-title":"Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice","volume":"6","author":"Hora","year":"2003"},{"key":"10.1016\/j.heliyon.2023.e18090_bib184","first-page":"423","article-title":"Anthocyanin\u2010and hydrolyzable tannin\u2010rich pomegranate fruit extract modulates MAPK and NF\u2010\u03baB pathways and inhibits skin tumorigenesis in CD\u20101 mice","volume":"113","author":"Afaq","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e18090_bib185","first-page":"1318","article-title":"Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation\u2010induced carcinogenesis in SKH\u20101 hairless mouse epidermis","volume":"86","author":"Afaq","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib186","first-page":"1511","article-title":"Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs\/NF-\u03baB and reduced cell proliferation","volume":"49","author":"George","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib187","first-page":"725","article-title":"Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation","volume":"23","author":"Sreeja","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e18090_bib188","first-page":"5697","article-title":"Anti tumoral properties of Punica granatum (Pomegranate) peel extract on different human cancer cells","volume":"16","author":"Modaeinama","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib189","first-page":"1119","article-title":"Anti tumoral properties of Punica granatum (Pomegranate) seed extract in different human cancer cells","volume":"17","author":"Seidi","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib190","first-page":"990","article-title":"Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9","volume":"18","author":"Liu","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib191","first-page":"29","article-title":"Ellagic acid induces HeLa cell apoptosis via regulating signal transducer and activator of transcription 3 signaling","volume":"16","author":"Li","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib192","first-page":"1411","article-title":"Punicalagin induces apoptotic and autophagic cell death in human U87MG glioma cells","volume":"34","author":"Wang","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib193","first-page":"30","article-title":"Diagnosis and treatment of patients with thyroid cancer","volume":"8","author":"Nguyen","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e18090_bib194","first-page":"193","article-title":"Thyroid cancer: burden of illness and management of disease","volume":"2","author":"Brown","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e18090_bib195","first-page":"63","article-title":"Punicalagin from pomegranate promotes human papillary thyroid carcinoma BCPAP cell death by triggering ATM-mediated DNA damage response","volume":"47","author":"Yao","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib196","doi-asserted-by":"crossref","unstructured":"S. L. Teniente, A. C. Flores-Gallegos, S. C. Esparza-Gonz\u00e1lez, L. G. Campos-M\u00fazquiz, S. D. Nery-Flores, and R. Rodr\u00edguez-Herrera, Anticancer effect of pomegranate peel polyphenols against cervical cancer. Antioxidants, vol. 12, pp.127. 2023.","DOI":"10.3390\/antiox12010127"},{"key":"10.1016\/j.heliyon.2023.e18090_bib197","first-page":"68485","article-title":"Punicalagin induces apoptosis-independent autophagic cell death in human papillary thyroid carcinoma BCPAP cells","volume":"6","author":"Cheng","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib198","first-page":"490","article-title":"Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-\u03baB signaling pathway","volume":"103","author":"Cheng","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib199","first-page":"84523","article-title":"Punica granatum (pomegranate) peel extract exerts potent antitumor and anti-metastasis activity in thyroid cancer","volume":"6","author":"Li","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e18090_bib200","article-title":"Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line","volume":"2012","author":"Berrington","year":"2012","journal-title":"J. Evidence-Based Complementary Altern. Med."},{"key":"10.1016\/j.heliyon.2023.e18090_bib201","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.12659\/MSM.898658","article-title":"Inhibition of cervical cancer by promoting IGFBP7 expression using ellagic acid from pomegranate peel","volume":"22","author":"Guo","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.heliyon.2023.e18090_bib202","first-page":"3016","article-title":"Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro","volume":"56","author":"McDougall","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib203","first-page":"6618","article-title":"Finding solutions for agricultural wastes: antioxidant and antitumor properties of pomegranate Akko peel extracts and \u03b2-glucan recovery","volume":"9","author":"Fazio","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e18090_bib204","first-page":"1439","article-title":"Punicalagin suppresses the proliferation and invasion of cervical cancer cells through inhibition of the \u03b2-catenin pathway","volume":"16","author":"Tang","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e18090_bib205","first-page":"634","article-title":"Pomegranate extract, a prooxidant with antiproliferative and proapoptotic activities preferentially towards carcinoma cells","volume":"10","author":"H Weisburg","year":"2010"},{"key":"10.1016\/j.heliyon.2023.e18090_bib206","first-page":"10","volume":"62","author":"Siegle","year":"2012","journal-title":"Cancer statistics"},{"key":"10.1016\/j.heliyon.2023.e18090_bib207","first-page":"1","article-title":"Antioxidant activity of pomegranate juice reduces acute lung injury secondary to hyperoxia in an animal model","volume":"7","author":"Husari","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib208","first-page":"1983","article-title":"Carvacrol and pomegranate extract in treating methotrexate-induced lung oxidative injury in rats","volume":"20","author":"\u015een","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e18090_bib209","first-page":"1120","article-title":"A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy","volume":"6","author":"Freedland","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e18090_bib210","first-page":"113","article-title":"Punica granatum L.(Dadim) Punica granatum L.(Dadim), therapeutic importance of world's most ancient fruit plant","volume":"11","author":"Kumari","year":"2021","journal-title":"Therapeutics"},{"key":"10.1016\/j.heliyon.2023.e18090_bib211","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11101-019-09629-9","article-title":"Importance of ethnopharmacological studies in drug discovery: role of medicinal plants","volume":"19","author":"S\u00fcntar","year":"2020","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.heliyon.2023.e18090_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113256","article-title":"Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L.(pomegranate) plant extracts: a review","volume":"153","author":"Maphetu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e18090_bib213","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5297162","article-title":"Therapeutic effects of Punica granatum (pomegranate): an updated review of clinical trials","volume":"2021","author":"Eghbali","year":"2021","journal-title":"Journal of Nutrition and Metabolism"},{"key":"10.1016\/j.heliyon.2023.e18090_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105145","article-title":"Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: in silico and in vitro studies","volume":"114","author":"Suru\u010di\u0107","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ptr.6565","article-title":"Antiinflammatory and anti\u2010cancer activities of pomegranate and its constituent, ellagic acid: evidence from cellular, animal, and clinical studies","volume":"34","author":"Baradaran Rahimi","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2023.e18090_bib216","article-title":"Photo-activated synthesis and characterization of gold nanoparticles from Punica granatum L. seed oil: an assessment on antioxidant and anticancer properties for functional yoghurt nutraceuticals","volume":"206","author":"Lydia","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib217","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.tetlet.2019.03.056","article-title":"Punicagranine, a new pyrrolizine alkaloid with anti-inflammatory activity from the peels of Punica granatum","volume":"60","author":"Sun","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.heliyon.2023.e18090_bib218","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.sajb.2021.01.006","article-title":"Global documentation of traditionally used medicinal plants in cancer management: a systematic review","volume":"138","author":"Aumeeruddy","year":"2021","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.heliyon.2023.e18090_bib219","doi-asserted-by":"crossref","unstructured":"A. A. Farooqi, August. Regulation of deregulated cell signaling pathways by pomegranate in different cancers: Re-interpretation of knowledge gaps vol. 73, pp. 294-301.","DOI":"10.1016\/j.semcancer.2021.01.008"},{"key":"10.1016\/j.heliyon.2023.e18090_bib220","series-title":"Seminars in Cancer Biology","first-page":"265","article-title":"Pomegranate bioactive constituents target multiple oncogenic and oncosuppressive signaling for cancer prevention and intervention","author":"Wong","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e18090_bib221","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ncponc0195","article-title":"Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer","volume":"2","author":"Haura","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib222","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.2174\/0929867325666180719122729","article-title":"Signal transducer and activator of transcription protein 3 (STAT3): an update on its direct inhibitors as promising anticancer agents","volume":"26","author":"Gelain","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib223","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.06.006","article-title":"Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?","volume":"191","author":"Beebe","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18090_bib224","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbcan.2013.12.005","article-title":"Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.heliyon.2023.e18090_bib225","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2020.100837","article-title":"Ellagic acid inhibited cervical cancer growth via blocking the AKT\/mTOR\/STAT3 pathway","author":"Xia","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18090_bib226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1562\/2005-06-23-RA-589","article-title":"Photochemopreventive effect of pomegranate fruit extract on UVA\u2010mediated activation of cellular pathways in normal human epidermal keratinocytes","volume":"82","author":"Syed","year":"2006","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib227","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/jm300207s","article-title":"Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein","volume":"55","author":"Debnath","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib228","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.heliyon.2023.e18090_bib229","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/cmdc.201100194","article-title":"Antagonism of the stat3\u2013stat3 protein dimer with salicylic acid based small molecules","volume":"6","author":"Fletcher","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.heliyon.2023.e18090_bib230","doi-asserted-by":"crossref","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib231","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40425-018-0436-5","article-title":"STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial","volume":"6","author":"Reilley","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.heliyon.2023.e18090_bib232","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00134-012-2498-z","article-title":"Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury","volume":"38","author":"Oyaizu","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.heliyon.2023.e18090_bib233","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1541-7786.170.2.3","article-title":"The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells","volume":"2","author":"Nagel-Wolfrum","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.heliyon.2023.e18090_bib234","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.4161\/cc.25365","article-title":"HIC1 interacts with and modulates the activity of STAT3","volume":"12","author":"Lin","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.heliyon.2023.e18090_bib235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2019.10.005","article-title":"Novel activators and small-molecule inhibitors of STAT3 in cancer","volume":"49","author":"Yang","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2023.e18090_bib236","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/acs.jmedchem.5b01814","article-title":"Preclinical characterization of 3beta-(N-acetyl l-cysteine methyl ester)-2abeta,3-dihydrogaliellalactone (GPA512), a prodrug of a direct STAT3 inhibitor for the treatment of prostate cancer","volume":"59","author":"Escobar","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e18090_bib237","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MPH.0000000000000329","article-title":"PI3King the lock: targeting the PI3K\/Akt\/mTOR pathway as a novel therapeutic strategy in neuroblastoma","volume":"37","author":"King","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib238","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/akt\/mTOR pathway as a therapeutic target for colorectal Cancer: a review of preclinical and clinical evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e18090_bib239","first-page":"299","article-title":"Targeting the PI3K\/AKT\/mTOR signaling axis in children with hematologic malignancies","volume":"14","author":"Barrett","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.heliyon.2023.e18090_bib240","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2174\/1381612823666161116125218","article-title":"PI3K\/Akt\/mTOR intracellular pathway and breast Cancer: factors, mechanism and regulation","volume":"23","author":"Sharma","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2023.e18090_bib241","series-title":"Seminars in Cancer Biology","first-page":"125","article-title":"December. PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"vol. 59","author":"Alzahrani","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e18090_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110484","article-title":"Marine compounds targeting the PI3K\/Akt signaling pathway in cancer therapy","volume":"129","author":"Wei","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e18090_bib243","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11130-019-00776-0","article-title":"Pomegranate juice and peel extracts are able to inhibit proliferation, migration and colony formation of prostate cancer cell lines and modulate the Akt\/mTOR\/S6K signaling pathway","volume":"75","author":"Chaves","year":"2020","journal-title":"Plant Foods Hum. Nutr."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18090_bib244","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.annonc.2020.01.074","article-title":"A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer","volume":"31","author":"Kolinsky","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1479-5876-11-241","article-title":"The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere","volume":"11","author":"Li","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.heliyon.2023.e18090_bib246","first-page":"2011","article-title":"Preclinical pharmacology of AZD5363, an orally bioavailable inhibitor of AKT: pharmacodynamics, antitumor activity and correlation of monotherapy activity with genetic background","author":"Davies","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.heliyon.2023.e18090_bib247","series-title":"Seminars in Oncology","article-title":"Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma","year":"2009"},{"issue":"22","key":"10.1016\/j.heliyon.2023.e18090_bib248","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e18090_bib249","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","article-title":"Phase 2 study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer","volume":"23","author":"Stephen","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18090_bib250","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-15-2225","article-title":"Phase I study of apitolisib (GDC-0980), dual Phosphatidylinositol-3-Kinase and mammalian target of rapamycin kinase inhibitor, in patients with advanced solid tumors","volume":"22","author":"Dolly","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18090_bib251","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/annonc\/mdw562","article-title":"A randomized adaptive phase II\/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)","volume":"28","author":"Martin","year":"2017","journal-title":"Ann. Oncol."},{"issue":"01","key":"10.1016\/j.heliyon.2023.e18090_bib252","first-page":"36","article-title":"DBS assay with LC-MS\/MS for the determination of Idelalisib, a selective PI3K-delta inhibitor in mice blood and its application to a pharmacokinetic study","volume":"71","author":"Tripathy","year":"2020","journal-title":"Drug Res"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e18090_bib253","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e18090_bib254","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1078-0432.CCR-13-1777","article-title":"Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors","volume":"20","author":"Shapiro","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18090_bib255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2014.12.019","article-title":"Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma","volume":"136","author":"Matulonis","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib256","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1158\/1535-7163.MCT-11-0185","article-title":"PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity","volume":"10","author":"Yuan","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.heliyon.2023.e18090_bib257","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-012-2224-0","article-title":"Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation","volume":"136","author":"Banerjee","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e18090_bib258","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1535-7163.MCT-18-0464","article-title":"Urolithin A, a novel natural compound to target PI3K\/AKT\/mTOR pathway in pancreatic CancerTargeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"18","author":"Totiger","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18090_bib259","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1349-7006.2006.00285.x","article-title":"Inhibition of tumor growth by NF\u2010\u03baB inhibitors","volume":"97","author":"Umezawa","year":"2006","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e18090_bib260","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/13543780903321490","article-title":"The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer","volume":"18","author":"Yong","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e18090_bib261","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cancers11101618","article-title":"A comprehensive review on MAPK: a promising therapeutic target in cancer","volume":"11","author":"Braicu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2023.e18090_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110569","article-title":"NF-\u03baB inhibitors in treatment and prevention of lung cancer","volume":"130","author":"Rasmi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e18090_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106398","article-title":"A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics","author":"Anjum","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e18090_bib264","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10408398.2019.1661827","article-title":"Targeting NF-\u03baB signaling pathway in cancer by dietary polyphenols","volume":"60","author":"Khan","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e18090_bib265","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1158\/1535-7163.MCT-07-0167","article-title":"TRAIL therapy in nonsmall cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib","volume":"6","author":"Voortman","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18090_bib266","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/JTO.0b013e3181aba89f","article-title":"A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer","volume":"4","author":"Lynch","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.heliyon.2023.e18090_bib267","series-title":"Proceedings of American Society of Clinical Oncology","first-page":"485a","article-title":"A randomized phase II trial comparing rhumab VEGF (recombinant humanized monoclonal antibody to vascular endothelial cell growth factor) plus carboplatin\/paclitaxel (CP) to CP alone in patients with stage IIIB\/IV NSCLC","volume":"vol. 19","author":"DeVore","year":"2000"},{"key":"10.1016\/j.heliyon.2023.e18090_bib268","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41388-017-0035-9","article-title":"Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers","volume":"37","author":"Kotani","year":"2018","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e18090_bib269","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/ijc.31603","article-title":"Phase I\/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer","volume":"143","author":"Van Cutsem","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e18090_bib270","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/nu9050436","article-title":"Anti-inflammatory mechanism involved in pomegranate-mediated prevention of breast cancer: the role of NF-\u03baB and Nrf2 signaling pathways","volume":"9","author":"Mandal","year":"2017","journal-title":"Nutrients"}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2023.e18090","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}},{"DOI":"10.1016\/j.heliyon.2025.e44130","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}},{"DOI":"10.1016\/j.heliyon.2025.e44130","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"record-id":"71157"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023052982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:58:58Z","timestamp":1766170738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023052982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":270,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2405844023052982"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18090","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e18090"}}